9 hours Pfizer Has a New Playbook for Reviving Sales—and It’s Starting to Pay Off Yahoo Finance

   X     

3 days The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J Zacks

   X     

4 days Pfizer (PFE) Stock Moves -0.43%: What You Should Know Zacks

   X     

4 days Calls of the Day: Invitation Homes, Pfizer and Roblox YouTube

   X     

4 days Arvinas (ARVN) Moves 8.8% Higher: Will This Strength Last? Zacks

   X     

5 days ARVN Stock Plunges 53% Following Mixed Data From Breast Cancer Study Zacks

   X     

6 days Arvinas Plummets 53% On Mixed Results For Its Pfizer-Tied Breast Cancer Drug Investor's Business Daily

   X     

6 days Pfizer: Undervalued Safe Haven In Risk-Off Market​ Seeking Alpha

   X     

1 week Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold? Zacks

   X     

1 week Pfizer Vs. Johnson & Johnson: Who’s The Better Bargain For Investors Seeking Alpha

   X     

2 weeks Final Trades: Pfizer, Paychex and the JEPI YouTube

   X     

2 weeks Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound? Zacks

   X     

2 weeks Here’s Why Moderna Stock Soared 16% on Wednesday Zacks

   X     

2 weeks German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent Yahoo Finance

   X     

2 weeks Pfizer: It’s Time To Play Defensive Seeking Alpha

   X     

2 weeks Pfizer Remains A Good Pick For Dividend Investors Seeking Alpha

   X     

2 weeks Pfizer’s CEO says he’s got a plan to deal with Trump’s tariffs — move overseas drug manufacturing to the US Business Insider

   X     

2 weeks Pfizer could use existing US manufacturing to counter potential tariff hit Investing.com

   X     

2 weeks Pfizer Inc. (PFE) TD Cowen 45th Annual Health Care Conference (Transcript) Seeking Alpha

   X     

3 weeks Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer Zacks

   X     

3 weeks The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO Zacks

   X     

3 weeks Top Research Reports for Alibaba, Pfizer & MercadoLibre Zacks

   X     

3 weeks Pfizer: What The Summit Therapeutics Deal Brings Seeking Alpha

   X     

3 weeks Vaccine Stocks Rise as Chinese Scientists Discover a New Coronavirus Zacks

   X     

3 weeks Summit Therapeutics shares rise on Pfizer trial collaboration Investing.com

   X     

3 weeks Pfizer: No More Growth – Still A Worthy Dividend Buy Seeking Alpha

   X     

3 weeks Pfizer: Investors Won’t Stick Around Forever Seeking Alpha

   X     

3 weeks Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair Yahoo Finance

   X     

4 weeks Pfizer ends global development of Beqvez gene therapy Investing.com

   X     

4 weeks Why Pfizer’s Stock Price Isn’t Reflecting Its True Value Seeking Alpha

   X     

4 weeks Pfizer Stock’s Upside Got Bigger Seeking Alpha

   X     

4 weeks Pfizer CEO Albert Bourla: Focusing on opportunities outside of vaccines with RFK Jr. YouTube

   X     

4 weeks Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell Seeking Alpha

   X     

1 month Pfizer: 3 Key Risks That Warrant A Sell Seeking Alpha

   X     

1 month Sangamo Therapeutics: Challenging Road Ahead After Pfizer Exit Seeking Alpha

   X     

1 month Pfizer: Challenges Loom Amid Overvaluation Seeking Alpha

   X     

1 month Fighting Cancer Becomes Top Priority for Pfizer YouTube

   X     

1 month Pfizer’s cancer frontier #shorts #wallstreetweek #pfizer YouTube

   X     

1 month The faulty forecasts of pharma firm investors: Misguided cynics miss the promising prognosis for drugmakers Pfizer and Merck Fortune

   X     

1 month Pfizer, Inc. (PFE) Q4 2024 Earnings Call Transcript Seeking Alpha

   X     

1 month Pfizer Q4 Earnings: Solid Results, But Guidance And Patent Concerns Drive The Stock Down Seeking Alpha

   X     

1 month Pfizer (PFE) Q4 2024 Earnings Call Transcript Yahoo Finance

   X     

1 month Pfizer’s Q4 Earnings Beat Estimates, Non-Covid Drugs Drive Sales Zacks

   X     

1 month Pfizer shows profit growth from cost cuts and steadier COVID sales Investing.com

   X     

1 month Pre-Markets Flat Ahead of JOLTS; Q4 Earnings for PFE, PYPL, PEP & More Zacks

   X     

1 month Pfizer beats Q4, FY ’24 earnings estimates, stock flat in early trading Yahoo Finance

   X     

1 month Compared to Estimates, Pfizer (PFE) Q4 Earnings: A Look at Key Metrics Zacks

   X     

1 month PFE’s Colorectal Cancer Drug Meets Other Dual Primary Goal of PFS Zacks

   X     

1 month Pfizer Q4 Earnings: Revenue And EPS Beat, Seagen And COVID-19 Products Show Strength, Issues Strong FY25 Outlook Yahoo Finance

   X     

1 month Pfizer’s Covid Products Drove Its Fourth-Quarter Upside. But Is It Sustainable? Investor's Business Daily

   X